Stock Analiz

ASP Isotopes Inc. ASPI

Major Chemicals · IPO 2022 · data as of November 13, 2026

$1.74Market cap $267M
Open the interactive analysis →

ASP Isotopes Inc. (ASPI) is a industrial company listed in the US with a market value of about $267M. In the twelve months to June 30, 2026 it had revenue of $31M and net income of -$117M, a net margin of -380.3%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -50%.

About ASP Isotopes

ASP Isotopes is listed in the US and classified in major chemicals, IPO year 2022. It was profitable in 0 of the last 4 years in our data. Its share count rose by 210% over three years (dilution for shareholders). It spends 52% of revenue on research and development.

Score: 1.0 / 5

Value0/5
Future growth3/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S8.6
P/B1.0
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-31.3%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)475.5%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-1738.5%
ROIC (5-yr avg.)-49.5%
Profitable years (of last 10)0
Years paying a dividend1

Financials, last 4 years

Fiscal yearTTM2025202420232022
Revenue$31M$24M$4M$433026$0
Net income-$117M-$160M-$32M-$16M-$5M
Free cash flow-$84M-$47M-$26M-$8M-$7M
EPS (diluted)$-1.49$-2.11$-0.63$-0.49$-0.18
Net margin-380.3%-670.2%-782.4%-3762.9%—
ROIC—-21.5%-40.4%-88.3%-47.9%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 3 analysts is $13.00, 647% above the current price; targets range from $11.00 to $15.00; the consensus rating is “none”; expected EPS is $-0.70 for the fiscal year ending December 31, 2026.

Frequently asked questions

Does ASP Isotopes pay a dividend?

Not currently.

Is ASP Isotopes a good stock to buy?

We do not give buy or sell advice. ASP Isotopes scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.